Biyomedikal Mühendisliği Bölümü Diğer Yayınlar Koleksiyonu

Bu koleksiyon için kalıcı URI

Güncel Gönderiler

Listeleniyor 1 - 18 / 18
  • Öğe
    Biotin-functionalized nanoparticles: an overview of recent trends in cancer detection
    (Royal soc chemistry, 2024) Fathi-karkan, Sonia; Sargazi, Saman; Shojaei, Shirin; Farasati Far, Bahareh; Mirinejad, Shekoufeh; Cordani, Marco; Khosravi, Arezoo; Zarrabi, Ali; Ghavami, Saeid
    Electrochemical bio-sensing is a potent and efficient method for converting various biological recognition events into voltage, current, and impedance electrical signals. Biochemical sensors are now a common part of medical applications, such as detecting blood glucose levels, detecting food pathogens, and detecting specific cancers. As an exciting feature, bio-affinity couples, such as proteins with aptamers, ligands, paired nucleotides, and antibodies with antigens, are commonly used as bio-sensitive elements in electrochemical biosensors. Biotin-avidin interactions have been utilized for various purposes in recent years, such as targeting drugs, diagnosing clinically, labeling immunologically, biotechnology, biomedical engineering, and separating or purifying biomolecular compounds. The interaction between biotin and avidin is widely regarded as one of the most robust and reliable noncovalent interactions due to its high bi-affinity and ability to remain selective and accurate under various reaction conditions and bio-molecular attachments. More recently, there have been numerous attempts to develop electrochemical sensors to sense circulating cancer cells and the measurement of intracellular levels of protein thiols, formaldehyde, vitamin-targeted polymers, huwentoxin-I, anti-human antibodies, and a variety of tumor markers (including alpha-fetoprotein, epidermal growth factor receptor, prostate-specific Ag, carcinoembryonic Ag, cancer antigen 125, cancer antigen 15-3, etc.). Still, the non-specific binding of biotin to endogenous biotin-binding proteins present in biological samples can result in false-positive signals and hinder the accurate detection of cancer biomarkers. This review summarizes various categories of biotin-functional nanoparticles designed to detect such biomarkers and highlights some challenges in using them as diagnostic tools. Biotin-functionalized nanoparticles enhance cancer detection by targeting biotin receptors, which are overexpressed on cancer cells. This targeted approach improves imaging accuracy and efficacy in identifying cancerous tissues.
  • Öğe
    Micelle-engineered nanoplatforms for precision oncology
    (Elsevier science, 2024) Gao, Wei; Bigham, Ashkan; Ghomi, Matineh; Zarrabi, Ali; Rabiee, Navid; Saeb, Mohammad Reza; Ertaş, Yavuz Nuri; Goel, Arul; Sharifi, Esmaeel; Ashrafizadeh, Milad; Sethi, Gautam; Tambuwala, Murtaza M.; Wang, Yuzhuo; Ghaffarlou, Mohammadreza; Jiao, Taiwei
    The alliance between nanomaterials and cancer therapy has revolutionized the treatment of tumor patients. After cardiovascular diseases, cancer is the leading cause of death, so interdisciplinary approaches should be used for the treatment of this malignant disease. Both treatment and early diagnosis of cancer are challenging. The micelles belong to lipid-based nanostructures, and they have a hydrophobic core with hydrophilic head regions. The current review article focuses on the application of micelles in cancer suppression. The micelles can provide a platform for co-delivery of non-coding RNAs and RNAi in cancer gene therapy. Both synthetic and natural
  • Öğe
    Next-generation nitrogen fixation strategy: empowering electrocatalysis with MXenes
    (Royal society of chemistry, 2024) Iravani, Siavash; Zarepour, Atefeh; Khosravi, Arezoo; Varma, Rajender S.; Zarrabi, Ali
    In recent years, the development of sustainable and cost-effective electrocatalysts for nitrogen (N2) fixation has garnered significant attention, leading to the introduction of next-generation materials with electrocatalytic properties. Among the most interesting types of these materials, MXenes and their composite forms with their unique properties like high electrochemical activity, large surface area, tunable properties, excellent electrical conductivity, chemical stability, and abundant transition metals have been widely explored. These properties make MXenes promising candidates for various electrochemical reactions, including water splitting, oxygen reduction, hydrogen evolution, N2 activation and reduction, among others. The interface of these materials could be engineered with other entities which can serve as a promising tool for sustainable production of ammonia (NH3) to address the global nitrogen-related challenges. Moreover, optimizing the interfaces between them and reactants is another way to achieve high catalytic activity, selectivity, and stability. Accordingly, this review aims to offer a comprehensive overview of the current state of research in the field of electrocatalytic N2 fixation deploying MXenes and their composites. The highlights comprise progress made in understanding the catalytic properties and unique performances of MXenes for N2 fixation, as well as challenges that persist in this context and the possible solutions that could be implemented to circumvent these challenges in the future. MXenes offer environmentally friendly alternatives to conventional N2 fixation methods via potential optimization of their catalytic activity and circumventing some synthesis challenges.
  • Öğe
    Nanoliposomes as nonviral vectors in cancer gene therapy
    (John Wiley and Sons Inc, 2024) Yıldız, Safiye Nur; Entezari, Maliheh; Paskeh, Mahshid Deldar Abad; Mirzaei, Sepideh; Kalbasi, Alireza; Zabolian, Amirhossein; Hashemi, Farid; Hushmandi, Kiavash; Hashemi, Mehrdad; Raei, Mehdi; Goharrizi, Mohammad Ali Sheikh Beig; Aref, Amir Reza; Zarrabi, Ali; Ren, Jun; Orive, Gorka; Rabiee, Navid; Ertaş, Yavuz Nuri
    Nonviral vectors, such as liposomes, offer potential for targeted gene delivery in cancer therapy. Liposomes, composed of phospholipid vesicles, have demonstrated efficacy as nanocarriers for genetic tools, addressing the limitations of off-targeting and degradation commonly associated with traditional gene therapy approaches. Due to their biocompatibility, stability, and tunable physicochemical properties, they offer potential in overcoming the challenges associated with gene therapy, such as low transfection efficiency and poor stability in biological fluids. Despite these advancements, there remains a gap in understanding the optimal utilization of nanoliposomes for enhanced gene delivery in cancer treatment. This review delves into the present state of nanoliposomes as carriers for genetic tools in cancer therapy, sheds light on their potential to safeguard genetic payloads and facilitate cell internalization alongside the evolution of smart nanocarriers for targeted delivery. The challenges linked to their biocompatibility and the factors that restrict their effectiveness in gene delivery are also discussed along with exploring the potential of nanoliposomes in cancer gene therapy strategies by analyzing recent advancements and offering future directions. © 2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
  • Öğe
    MXene-based composites in smart wound healing and dressings
    (Royal society of chemistry, 2024) Zarepour, Atefeh; Rafati, Nesa; Khosravi, Arezoo; Rabiee, Navid; Iravani, Siavash; Zarrabi, Ali
    MXenes, a class of two-dimensional materials, exhibit considerable potential in wound healing and dressing applications due to their distinctive attributes, including biocompatibility, expansive specific surface area, hydrophilicity, excellent electrical conductivity, unique mechanical properties, facile surface functionalization, and tunable band gaps. These materials serve as a foundation for the development of advanced wound healing materials, offering multifunctional nanoplatforms with theranostic capabilities. Key advantages of MXene-based materials in wound healing and dressings encompass potent antibacterial properties, hemostatic potential, pro-proliferative attributes, photothermal effects, and facilitation of cell growth. So far, different types of MXene-based materials have been introduced with improved features for wound healing and dressing applications. This review covers the recent advancements in MXene-based wound healing and dressings, with a focus on their contributions to tissue regeneration, infection control, anti-inflammation, photothermal effects, and targeted therapeutic delivery. We also discussed the constraints and prospects for the future application of these nanocomposites in the context of wound healing/dressings. Recent advancements in MXene-based wound dressings are discussed, focusing on their contributions to tissue regeneration, infection control, anti-inflammation and photothermal effects, and targeted therapeutic delivery.
  • Öğe
    Self-healing materials in biomedicine and the circular economy
    (Royal Soc Chemistry, 2024) Venkateswaran, Meenakshi R.; Khosravi, Arezoo; Zarepour, Atefeh; Iravani, Siavash; Zarrabi, Ali
    Self-healing (bio)materials represent a cornerstone in the transition towards a circular economy in healthcare. These materials possess the remarkable ability to autonomously repair damage, thereby extending the lifespan of medical devices, implants, sensors, wound dressings, and drug delivery systems. By extending the lifespan of biomedical products, they can significantly reduce waste generation and minimize the environmental impact associated with frequent replacement. In addition, the integration of self-healing properties into drug delivery systems can enhance their efficacy and reduce the need for frequent administration, resulting in a more sustainable healthcare system. Notably, self-healing polymers and hydrogels have the potential to improve the durability and lifespan of wound dressings, providing extended protection and support throughout the healing process. The development and implementation of self-healing biomaterials signify a shift towards a more environmentally conscious and resource-efficient healthcare sector. By adopting a circular approach, healthcare facilities can optimize the use of resources throughout the product lifecycle. This includes designing medical devices with self-healing capabilities, implementing efficient recycling systems, and promoting the development of new materials from recycled sources. Such an approach not only reduces the environmental footprint of the healthcare sector but also contributes to a more sustainable and resilient supply chain. The adoption of self-healing (bio)materials offers numerous benefits for the healthcare industry. These materials not only can reduce the environmental impact of medical practices by extending the lifecycle of products but also enhance patient safety and treatment outcomes. The integration of self-healing materials in the healthcare industry holds promise for supporting a more circular economy by extending the product lifespan, reducing waste generation, and fostering sustainable practices in medical settings. However, additional explorations are warranted to optimize the performance and stability of self-healing (bio)materials, ensuring their long-term effectiveness. One of the primary challenges in the adoption of self-healing materials is the cost associated with their production. Notably, the exploration of specific self-healing mechanisms will be crucial in expanding their applications. This review examines the intersection of self-healing materials, biomedicine, and the circular economy, focusing on the challenges, advantages, and future perspectives associated with their implementation. This review examines the intersection of self-healing materials, biomedicine, and the circular economy, focusing on the challenges, advantages, and future perspectives associated with their implementation.
  • Öğe
    Glycosylated nanoplatforms: From glycosylation strategies to implications and opportunities for cancer theranostics
    (Elsevier B.V., 2024) Zare, Iman; Zirak Hassan Kiadeh, Shahrzad; Varol, Ayşegül; Ören Varol, Tuğba; Varol, Mehmet; Sezen, Serap; Zarepour, Atefeh; Mostafavi, Ebrahim; Zahed Nasab, Shima; Rahi, Amid; Khosravi, Arezoo; Zarrabi, Ali
    Glycosylated nanoplatforms have emerged as promising tools in the field of cancer theranostics, integrating both therapeutic and diagnostic functionalities. These nanoscale platforms are composed of different materials such as lipids, polymers, carbons, and metals that can be modified with glycosyl moieties to enhance their targeting capabilities towards cancer cells. This review provides an overview of different modification strategies employed to introduce glycosylation onto nanoplatforms, including chemical conjugation, enzymatic methods, and bio-orthogonal reactions. Furthermore, the potential applications of glycosylated nanoplatforms in cancer theranostics are discussed, focusing on their roles in drug delivery, imaging, and combination therapy. The ability of these nanoplatforms to selectively target cancer cells through specific interactions with overexpressed glycan receptors is highlighted, emphasizing their potential for enhancing efficacy and reducing the side effects compared to conventional therapies. In addition, the incorporation of diagnostic components onto the glycosylated nanoplatforms provided the capability of simultaneous imaging and therapy and facilitated the real-time monitoring of treatment response. Finally, challenges and future perspectives in the development and translation of glycosylated nanoplatforms for clinical applications are addressed, including scalability, biocompatibility, and regulatory considerations. Overall, this review underscores the significant progress made in the field of glycosylated nanoplatforms and their potential to revolutionize cancer theranostics. © 2024 Elsevier B.V.
  • Öğe
    c-FLIP/Ku70 complex; A potential molecular target for apoptosis induction in hepatocellular carcinoma
    (Academic press inc., 2025) Haghir-Sharif-Zamini, Yasamin; Khosravi, Arezoo; Hassan, Moustapha; Zarrabi, Ali; Vosough, Massoud
    Hepatocellular carcinoma (HCC) is one of the most lethal malignancies worldwide and the most common form of liver cancer. Despite global efforts toward early diagnosis and effective treatments, HCC is often diagnosed at advanced stages, where conventional therapies frequently lead to resistance and/or high recurrence rates. Therefore, novel biomarkers and promising medications are urgently required. Epi-drugs, or epigenetic-based medicines, have recently emerged as a promising therapeutic modality. Since the epigenome of the cancer cells is always dysregulated and this is followed by apoptosis-resistance, reprogramming the epigenome of cancer cells by epi-drugs (such as HDAC inhibitors (HDACis), and DNMT inhibitors (DNMTis)) could be an alternative approach to use in concert with established treatment protocols. C-FLIP, an anti-apoptotic protein, and Ku70, a member of the DNA repair system, bind together and make a cytoplasmic complex in certain cancers and induce resistance to apoptosis. Many epi-drugs, such as HDACis, can dissociate this complex through Ku70 acetylation and activate cellular apoptosis. The novel compounds for dissociating this complex could provide an innovative insight into molecular targeted HCC treatments. In this review, we address the innovative therapeutic potential of targeting c-FLIP/Ku70 complex by epi-drugs, particularly HDACis, to overcome apoptosis resistance of HCC cells. This review will cover the mechanisms by which the c-FLIP/Ku70 complex facilitates cancer cell survival, the impact of epigenetic alterations on the complex dissociation, and highlight HDACis potential in combination therapies, biomarker developments and mechanistic overviews. This review highlights c-FLIP ubiquitination and Ku70 acetylation levels as diagnostic and prognostic tools in HCC management.
  • Öğe
    Intersecting pathways: The role of hybrid E/M cells and circulating tumor cells in cancer metastasis and drug resistance
    (Churchill Livingstone, 2024) Hariri, Amirali; Mirian, Mina; Khosravi, Arezoo; Zarepour, Atefeh; Iravani, Siavash; Zarrabi, Ali
    Cancer metastasis and therapy resistance are intricately linked with the dynamics of Epithelial-Mesenchymal Transition (EMT) and Circulating Tumor Cells (CTCs). EMT hybrid cells, characterized by a blend of epithelial and mesenchymal traits, have emerged as pivotal in metastasis and demonstrate remarkable plasticity, enabling transitions across cellular states crucial for intravasation, survival in circulation, and extravasation at distal sites. Concurrently, CTCs, which are detached from primary tumors and travel through the bloodstream, are crucial as potential biomarkers for cancer prognosis and therapeutic response. There is a significant interplay between EMT hybrid cells and CTCs, revealing a complex, bidirectional relationship that significantly influences metastatic progression and has a critical role in cancer drug resistance. This resistance is further influenced by the tumor microenvironment, with factors such as tumor-associated macrophages, cancer-associated fibroblasts, and hypoxic conditions driving EMT and contributing to therapeutic resistance. It is important to understand the molecular mechanisms of EMT, characteristics of EMT hybrid cells and CTCs, and their roles in both metastasis and drug resistance. This comprehensive understanding sheds light on the complexities of cancer metastasis and opens avenues for novel diagnostic approaches and targeted therapies and has significant advancements in combating cancer metastasis and overcoming drug resistance. © 2024 Elsevier Ltd
  • Öğe
    Promising breakthroughs in amyotrophic lateral sclerosis treatment through nanotechnology's unexplored frontier
    (Elsevier masson s.r.l., 2025) Sojdeh, Soheil; Safarkhani, Moein; Daneshgar, Hossein; Aldhaher, Abdullah; Heidari, Golnaz; Nazarzadeh Zare, Ehsan; Iravani, Siavash; Zarrabi, Ali; Rabiee, Navid
    This review explores the transformative potential of nanotechnology in the treatment and diagnosis of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disorder characterized by motor neuron degeneration, muscle weakness, and eventual paralysis. Nanotechnology offers innovative solutions across various domains, including targeted drug delivery, neuroprotection, gene therapy and editing, biomarker detection, advanced imaging techniques, and tissue engineering. By enhancing the precision and efficacy of therapeutic interventions, nanotechnology facilitates key advancements such as crossing the blood-brain barrier, targeting specific cell types, achieving sustained therapeutic release, and enabling combination therapies tailored to the complex pathophysiology of ALS. Despite its immense promise, the clinical translation of these approaches faces challenges, including potential cytotoxicity, biocompatibility, and regulatory compliance, which must be addressed through rigorous research and testing. This review emphasizes the application of nanotechnology in targeted drug delivery and gene therapy/editing for ALS, drawing on the author's prior work with various nanotechnological platforms to illustrate strategies for overcoming similar obstacles in drug and gene delivery. By bridging the gap between cutting-edge technology and clinical application, this article aims to highlight the vital role of nanotechnology in shaping the future of ALS treatment.
  • Öğe
    Carbon-based nanozymes for cancer therapy and diagnosis: a review
    (Elsevier b.v., 2025) Cordani, Marco; Fernández-Lucas, Jesús; Khosravi, Arezoo; Zare, Ehsan Nazarzadeh; Makvandi, Pooyan; Zarrabi, Ali; Iravani, Siavash
    Carbon-based nanozymes (CNs) have emerged as a significant innovation in targeted cancer therapy, demonstrating great potential for advancing cancer diagnosis and treatment. With exceptional catalytic properties, remarkable biocompatibility, and the ability to precisely target cancer cells, CNs provide a promising avenue for the development of novel oncological therapies. By functionalizing their surfaces with targeting ligands, such as antibodies or peptides, CNs can specifically recognize and bind to cancer cells. This targeted approach ensures that therapeutic agents are delivered directly to the tumor site, minimizing off-target effects, and reducing systemic toxicity. Additionally, the enzyme-like activities of CNs, when combined with conventional therapies such as chemotherapeutics, photothermal therapy, and photodynamic therapy, or other modalities can enhance therapeutic outcomes. Integrating CNs into clinical practice could significantly improve therapeutic efficacy, reduce probable side effects, enhance patient outcomes, and drive a shift towards more personalized cancer care. Besides, CNs can also be employed in biosensors and diagnostic nanomaterials, enabling rapid, selective, and highly accurate detection of specific biomarkers. Their versatile functionalities open new avenues for refining imaging techniques, ultimately contributing to early diagnosis and better clinical decision-making. This review consolidates recent studies exploring CNs in cancer targeting, highlighting both their diagnostic and therapeutic potential in oncology.
  • Öğe
    Catalytic and biomedical applications of nanocelluloses: A review of recent developments
    (Elsevier B.V., 2024) Khorsandi, D.; Jenson, S.; Zarepour, A.; Khosravi, A.; Rabiee, N.; Iravani, S.; Zarrabi A.
    Nanocelluloses exhibit immense potential in catalytic and biomedical applications. Their unique properties, biocompatibility, and versatility make them valuable in various industries, contributing to advancements in environmental sustainability, catalysis, energy conversion, drug delivery, tissue engineering, biosensing/imaging, and wound healing/dressings. Nanocellulose-based catalysts can efficiently remove pollutants from contaminated environments, contributing to sustainable and cleaner ecosystems. These materials can also be utilized as drug carriers, enabling targeted and controlled drug release. Their high surface area allows for efficient loading of therapeutic agents, while their biodegradability ensures safer and gradual release within the body. These targeted drug delivery systems enhance the efficacy of treatments and minimizes side effects. Moreover, nanocelluloses can serve as scaffolds in tissue engineering due to their structural integrity and biocompatibility. They provide a three-dimensional framework for cell growth and tissue regeneration, promoting the development of functional and biologically relevant tissues. Nanocellulose-based dressings have shown great promise in wound healing and dressings. Their ability to absorb exudates, maintain a moist environment, and promote cell proliferation and migration accelerates the wound healing process. Herein, the recent advancements pertaining to the catalytic and biomedical applications of nanocelluloses and their composites are deliberated, focusing on important challenges, advantages, limitations, and future prospects. © 2024 The Authors
  • Öğe
    The impact of nanomaterials on autophagy across health and disease conditions
    (Springer Science and Business Media Deutschland GmbH, 2024) Florance, I.; Cordani, M.; Pashootan, P.; Moosavi, M.A.; Zarrabi, A.; Chandrasekaran, N.
    Autophagy, a catabolic process integral to cellular homeostasis, is constitutively active under physiological and stress conditions. The role of autophagy as a cellular defense response becomes particularly evident upon exposure to nanomaterials (NMs), especially environmental nanoparticles (NPs) and nanoplastics (nPs). This has positioned autophagy modulation at the forefront of nanotechnology-based therapeutic interventions. While NMs can exploit autophagy to enhance therapeutic outcomes, they can also trigger it as a pro-survival response against NP-induced toxicity. Conversely, a heightened autophagy response may also lead to regulated cell death (RCD), in particular autophagic cell death, upon NP exposure. Thus, the relationship between NMs and autophagy exhibits a dual nature with therapeutic and environmental interventions. Recognizing and decoding these intricate patterns are essential for pioneering next-generation autophagy-regulating NMs. This review delves into the present-day therapeutic potential of autophagy-modulating NMs, shedding light on their status in clinical trials, intervention of autophagy in the therapeutic applications of NMs, discusses the potency of autophagy for application as early indicator of NM toxicity. Graphical Abstract: (Figure presented.). © The Author(s) 2024.
  • Öğe
    Self-healing MXene-and graphene-based composites : properties and applications
    (Springer, 2023) Zarepour, Atefeh; Ahmadi, Sepideh; Rabiee, Navid; Zarrabi, Ali; Iravani, Siavash
    Today, self-healing graphene- and MXene-based composites have attracted researchers due to the increase in durability as well as the cost reduction in long-time applications. Different studies have focused on designing novel self-healing graphene- and MXene-based composites with enhanced sensitivity, stretchability, and flexibility as well as improved electrical conductivity, healing efficacy, mechanical properties, and energy conversion efficacy. These composites with self-healing properties can be employed in the field of wearable sensors, supercapacitors, anticorrosive coatings, electromagnetic interference shielding, electronic-skin, soft robotics, etc. However, it appears that more explorations are still needed to achieve composites with excellent arbitrary shape adaptability, suitable adhesiveness, ideal durability, high stretchability, immediate self-healing responsibility, and outstanding electromagnetic features. Besides, optimizing reaction/synthesis conditions and finding suitable strategies for functionalization/modification are crucial aspects that should be comprehensively investigated. MXenes and graphene exhibited superior electrochemical properties with abundant surface terminations and great surface area, which are important to evolve biomedical and sensing applications. However, flexibility and stretchability are important criteria that need to be improved for their future applications. Herein, the most recent advancements pertaining to the applications and properties of self-healing graphene- and MXene-based composites are deliberated, focusing on crucial challenges and future perspectives.
  • Öğe
    Bioprinted membranes for corneal tissue engineering: a review
    (MDPI, 2022) Orash Mahmoud Salehi, Amin; Poursamar, Seyed Ali; Zarrabi, Ali; Sefat, Farshid; Mamidi, Narsimha; Behrouz, Mahmoud Jabbarvand; Rafienia, Mohammad
    Corneal transplantation is considered a convenient strategy for various types of corneal disease needs. Even though it has been applied as a suitable solution for most corneal disorders, patients still face several issues due to a lack of healthy donor corneas, and rejection is another unknown risk of corneal transplant tissue. Corneal tissue engineering (CTE) has gained significant consideration as an efficient approach to developing tissue-engineered scaffolds for corneal healing and regeneration. Several approaches are tested to develop a substrate with equal transmittance and mechanical properties to improve the regeneration of cornea tissue. In this regard, bioprinted scaffolds have recently received sufficient attention in simulating corneal structure, owing to their spectacular spatial control which produces a three-cell-loaded-dimensional corneal structure. In this review, the anatomy and function of different layers of corneal tissue are highlighted, and then the potential of the 3D bioprinting technique for promoting corneal regeneration is also discussed. © 2022 by the authors.
  • Öğe
    Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action
    (Springer Science and Business Media Deutschland GmbH, 2022) Behroozaghdam, Mitra; Dehghani, Maryam; Zabolian, Amirhossein; Kamali, Davood; Javanshir, Salar; Hasani Sadi, Farzaneh; Hashemi, Mehrdad; Tabari, Teimour; Rashidi, Mohsen; Mirzaei, Sepideh; Zarepour, Atefeh; Zarrabi, Ali; De Greef, Danielle; Bishayee, Anupam
    Breast cancer (BC) is one of the most common cancers in females and is responsible for the highest cancer-related deaths following lung cancer. The complex tumor microenvironment and the aggressive behavior, heterogenous nature, high proliferation rate, and ability to resist treatment are the most well-known features of BC. Accordingly, it is critical to find an effective therapeutic agent to overcome these deleterious features of BC. Resveratrol (RES) is a polyphenol and can be found in common foods, such as pistachios, peanuts, bilberries, blueberries, and grapes. It has been used as a therapeutic agent for various diseases, such as diabetes, cardiovascular diseases, inflammation, and cancer. The anticancer mechanisms of RES in regard to breast cancer include the inhibition of cell proliferation, and reduction of cell viability, invasion, and metastasis. In addition, the synergistic effects of RES in combination with other chemotherapeutic agents, such as docetaxel, paclitaxel, cisplatin, and/or doxorubicin may contribute to enhancing the anticancer properties of RES on BC cells. Although, it demonstrates promising therapeutic features, the low water solubility of RES limits its use, suggesting the use of delivery systems to improve its bioavailability. Several types of nano drug delivery systems have therefore been introduced as good candidates for RES delivery. Due to RES’s promising potential as a chemopreventive and chemotherapeutic agent for BC, this review aims to explore the anticancer mechanisms of RES using the most up to date research and addresses the effects of using nanomaterials as delivery systems to improve the anticancer properties of RES. Graphical abstract: [Figure not available: see fulltext.].
  • Öğe
    Non-coding RNAs targeting notch signaling pathway in cancer : from proliferation to cancer therapy resistance
    (Elsevier B.V., 2022) Hashemi, Mehrdad; Hasani, Sahar; Hajimazdarany, Shima; Mirmazloomi, Seyed Reza; Makvandy, Sara; Zabihi, Abbas; Goldoost, Yeganeh; Gholinia, Nazanin; Kakavand, Amirabbas; Tavakolpournegari, Alireza; Salimimoghadam, Shokooh; Nabavi, Noushin; Zarrabi, Ali; Taheriazam, Afshin; Entezari, Maliheh; Hushmandi, Kiavash
    Cancer is a challenging to treat disease with a high mortality rate worldwide, nevertheless advances in science has led to a decrease in the number of death cases caused by cancer. Aberrant expression of genes occurs during tumorigenesis therefore targeting the signaling pathways that regulate these genes' expression is of importance in cancer therapy. Notch is one of the signaling pathways having interactions with other vital cell signaling molecules responsible for cellular functions such as proliferation, apoptosis, invasion, metastasis, epithelial-to-mesenchymal transition (EMT), angiogenesis, and immune evasion. Furthermore, the Notch pathway is involved in response to chemo- and radiotherapy. Thus, targeting the Notch signaling pathway in cancer therapy can be beneficial for overcoming the therapeutic gaps. Non-coding RNAs (ncRNAs) are a class of RNAs that include short ncRNAs (such as micro RNAs) and long ncRNAs (lncRNAs). MicroRNAs (miRNAs) are ~22 nucleotides in length while lncRNAs have more than 200 nucleotides. Both miRNAs and lncRNAs control vital cellular mechanisms in cells and affect various signaling pathways and Notch is among them. The current review aims to discuss the critical role of ncRNAs in the regulation of the Notch signaling pathway by focusing on different cancer hallmarks including proliferation, apoptosis, autophagy, EMT, invasion, metastasis, and resistance to therapies.
  • Öğe
    Magnetic nanocomposites for biomedical applications
    (Elsevier B.V., 2022) Naghdi, Mina; Ghovvati, Mahsa; Rabiee, Navid; Ahmadi, Sepideh; Abbariki, Nikzad; Sojdeh, Soheil; Ojaghi, Amirhossein; Bagherzadeh, Mojtaba; Akhavan, Omid; Sharifi, Esmaeel; Rabiee, Mohammad; Saeb, Mohammad Reza; Bolouri, Keivan; Webster, Thomas J.; Zare, Ehsan Nazarzadeh; Zarrabi, Ali
    Tissue engineering and regenerative medicine have solved numerous problems related to the repair and regeneration of damaged organs and tissues arising from aging, illnesses, and injuries. Nanotechnology has further aided tissue regeneration science and has provided outstanding opportunities to help disease diagnosis as well as treat damaged tissues. Based on the most recent findings, magnetic nanostructures (MNSs), in particular, have emerged as promising materials for detecting, directing, and supporting tissue regeneration. There have been many reports concerning the role of these nano-building blocks in the regeneration of both soft and hard tissues, but the subject has not been extensively reviewed. Here, we review, classify, and discuss various synthesis strategies for novel MNSs used in medicine. Advanced applications of magnetic nanocomposites (MG-NCs), specifically magnetic nanostructures, are further systematically reviewed. In addition, the scientific and technical aspects of MG-NC used in medicine are discussed considering the requirements for the field. In summary, this review highlights the numerous opportunities and challenges associated with the use of MG-NCs as smart nanocomposites (NCs) in tissue engineering and regenerative medicine.